Semi-synthesis of novel thebaine derivatives with low cytotoxicity and their antibacterial and antihemolytic properties

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Semi-synthesis of novel thebaine derivatives with low cytotoxicity and their antibacterial and antihemolytic properties. / Hasanpour, Zahra; Salehi, Peyman; Aliahmadi, Atousa; Hoseinpour, Mahdieh; Behboodi, Hossein; Staerk, Dan; Bararjanian, Morteza.

In: Medicinal Chemistry Research, Vol. 32, 2023, p. 1713–1725.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hasanpour, Z, Salehi, P, Aliahmadi, A, Hoseinpour, M, Behboodi, H, Staerk, D & Bararjanian, M 2023, 'Semi-synthesis of novel thebaine derivatives with low cytotoxicity and their antibacterial and antihemolytic properties', Medicinal Chemistry Research, vol. 32, pp. 1713–1725. https://doi.org/10.1007/s00044-023-03074-2

APA

Hasanpour, Z., Salehi, P., Aliahmadi, A., Hoseinpour, M., Behboodi, H., Staerk, D., & Bararjanian, M. (2023). Semi-synthesis of novel thebaine derivatives with low cytotoxicity and their antibacterial and antihemolytic properties. Medicinal Chemistry Research, 32, 1713–1725. https://doi.org/10.1007/s00044-023-03074-2

Vancouver

Hasanpour Z, Salehi P, Aliahmadi A, Hoseinpour M, Behboodi H, Staerk D et al. Semi-synthesis of novel thebaine derivatives with low cytotoxicity and their antibacterial and antihemolytic properties. Medicinal Chemistry Research. 2023;32:1713–1725. https://doi.org/10.1007/s00044-023-03074-2

Author

Hasanpour, Zahra ; Salehi, Peyman ; Aliahmadi, Atousa ; Hoseinpour, Mahdieh ; Behboodi, Hossein ; Staerk, Dan ; Bararjanian, Morteza. / Semi-synthesis of novel thebaine derivatives with low cytotoxicity and their antibacterial and antihemolytic properties. In: Medicinal Chemistry Research. 2023 ; Vol. 32. pp. 1713–1725.

Bibtex

@article{e18d79c36eb945fca883c25570f0e5cd,
title = "Semi-synthesis of novel thebaine derivatives with low cytotoxicity and their antibacterial and antihemolytic properties",
abstract = "In the present study, some new 1,2,3-triazole-tethered analogs of N-northebaine were designed and synthesized. The anti-bacterial properties of novel thebaine derivatives were studied on Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Based on the results, compounds 5b, 5j and 5m showed the best activities against S. aureus (minimum inhibitory concentration (MIC) ~ 25 μM) compared to the parent compound (MIC ~ 321 μM). The most active anti-bacterial derivatives (i.e., 5b, 5j and 5m) and thebaine were considered as potent anti-bacterial wound healing agents. In this regard, fibroblast cell cytotoxicity and proliferation as well as anti-hemolytic activities of the mentioned compounds were studied. The cytotoxicity assay by using 3-[4,5-dimethylthiazol-2-yl] 2,5-diphenyltetrazolium bromide (MTT) on human dermal fibroblast cell lines (HDF) revealed that products 5j and 5m didn{\textquoteright}t show inhibition of cell line growth after 24 h. Based on the investigation results on blood cell disruption for releasing of hemoglobin, compound 5j didn{\textquoteright}t exhibit any hemolysis activity in different doses. Graphical Abstract: [Figure not available: see fulltext.]",
keywords = "1,2,3-Triazole, Blood hemolysis, Click chemistry, Cytotoxicity, Human fibroblast cell",
author = "Zahra Hasanpour and Peyman Salehi and Atousa Aliahmadi and Mahdieh Hoseinpour and Hossein Behboodi and Dan Staerk and Morteza Bararjanian",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",
year = "2023",
doi = "10.1007/s00044-023-03074-2",
language = "English",
volume = "32",
pages = "1713–1725",
journal = "Medicinal Chemistry Research",
issn = "1054-2523",
publisher = "Springer Basel AG",

}

RIS

TY - JOUR

T1 - Semi-synthesis of novel thebaine derivatives with low cytotoxicity and their antibacterial and antihemolytic properties

AU - Hasanpour, Zahra

AU - Salehi, Peyman

AU - Aliahmadi, Atousa

AU - Hoseinpour, Mahdieh

AU - Behboodi, Hossein

AU - Staerk, Dan

AU - Bararjanian, Morteza

N1 - Publisher Copyright: © 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

PY - 2023

Y1 - 2023

N2 - In the present study, some new 1,2,3-triazole-tethered analogs of N-northebaine were designed and synthesized. The anti-bacterial properties of novel thebaine derivatives were studied on Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Based on the results, compounds 5b, 5j and 5m showed the best activities against S. aureus (minimum inhibitory concentration (MIC) ~ 25 μM) compared to the parent compound (MIC ~ 321 μM). The most active anti-bacterial derivatives (i.e., 5b, 5j and 5m) and thebaine were considered as potent anti-bacterial wound healing agents. In this regard, fibroblast cell cytotoxicity and proliferation as well as anti-hemolytic activities of the mentioned compounds were studied. The cytotoxicity assay by using 3-[4,5-dimethylthiazol-2-yl] 2,5-diphenyltetrazolium bromide (MTT) on human dermal fibroblast cell lines (HDF) revealed that products 5j and 5m didn’t show inhibition of cell line growth after 24 h. Based on the investigation results on blood cell disruption for releasing of hemoglobin, compound 5j didn’t exhibit any hemolysis activity in different doses. Graphical Abstract: [Figure not available: see fulltext.]

AB - In the present study, some new 1,2,3-triazole-tethered analogs of N-northebaine were designed and synthesized. The anti-bacterial properties of novel thebaine derivatives were studied on Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Based on the results, compounds 5b, 5j and 5m showed the best activities against S. aureus (minimum inhibitory concentration (MIC) ~ 25 μM) compared to the parent compound (MIC ~ 321 μM). The most active anti-bacterial derivatives (i.e., 5b, 5j and 5m) and thebaine were considered as potent anti-bacterial wound healing agents. In this regard, fibroblast cell cytotoxicity and proliferation as well as anti-hemolytic activities of the mentioned compounds were studied. The cytotoxicity assay by using 3-[4,5-dimethylthiazol-2-yl] 2,5-diphenyltetrazolium bromide (MTT) on human dermal fibroblast cell lines (HDF) revealed that products 5j and 5m didn’t show inhibition of cell line growth after 24 h. Based on the investigation results on blood cell disruption for releasing of hemoglobin, compound 5j didn’t exhibit any hemolysis activity in different doses. Graphical Abstract: [Figure not available: see fulltext.]

KW - 1,2,3-Triazole

KW - Blood hemolysis

KW - Click chemistry

KW - Cytotoxicity

KW - Human fibroblast cell

U2 - 10.1007/s00044-023-03074-2

DO - 10.1007/s00044-023-03074-2

M3 - Journal article

AN - SCOPUS:85161471792

VL - 32

SP - 1713

EP - 1725

JO - Medicinal Chemistry Research

JF - Medicinal Chemistry Research

SN - 1054-2523

ER -

ID: 357511019